1. Comment to: Baloxavir efficacy in North American Adults.
- Author
-
Portsmouth S, Kawaguchi K, Uehara T, and Hayden FG
- Subjects
- Adult, Dibenzothiepins, Humans, Morpholines, Oxazines, Pyridines, Pyridones, Triazines, United States, Influenza, Human, Thiepins
- Abstract
Competing Interests: Declaration of Competing Interest Dr. Portsmouth, Ms. Kawaguchi, and Dr. Uehara are employees of Shionogi, Co., Ltd. Dr. Hayden reports travel support from Shionogi; personal fees from World Health Organization and from University of Alabama Antiviral Drug Discovery and Development Consortium; donations to the Ford Haitian Orphanage and School from Cidara, resTORbio, Seqirus, and Shionogi for consulting; payments to the University of Virginia from GSK, Celltrion, and Vaccitech for DSMB work; and having served as nonpaid consultant to various companies (CoCrystal, Farmak, FujiFilm/Toyama, GSK, Janssen, MedImmune, Regeneron, Roche/Genentech, SAB Biotherapeutics, Vir, Visterra) that are developing investigational therapeutics for influenza.
- Published
- 2020
- Full Text
- View/download PDF